All In MedTech

Device Trial Radar · NCT05152524

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 149 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

149

Actual

Start

Mar 25, 2022

Primary completion

Dec 30, 2025

Study completion Mar 30, 2026

Sponsor

Lead sponsor
Rapid MedicalNot on our public-company list
Sponsor type
Industry
First posted
Dec 10, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.

Conditions

  • Ischemic Stroke
  • Neovascularization

Interventions

  • Tigertriever 13Device

    patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO) will be treated with the Tigertriever 13 device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful reperfusion (CTP or MR PWI*) without sICH**.Time frame: 24±6 Hours post randomization

Locations

20 sites in 4 countries. Site status is shown where the registry gives one.

  • Lakewood Regional Medical Center

    Los Angeles, California

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.